인후두 역류증 환자에서 Reza Band 사용의 안전성 및 효과: 예비연구
Safety and Effectiveness of Reza Band in Management of Laryngopharyngeal Reflux Disease: A Preliminary Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Objectives The main treatment of laryngopharyngeal reflux disease(LPRD) includes life style modification and proton pump inhibitor (PPI) medication. However,LPRD is sometimes refractory to PPI medication. The Reza band has been developed toexert external pressure on the upper esophageal sphincter thus preventing gastric acid refluxto the larynx and pharynx. The aim of this study was to evaluate safety and efficacy of usingthe Reza band in patients with LPRD. Subjects and Methods We prospectively enrolled 16 LPRD patients who were refractoryto PPI medication and who had agreed to wear the Reza band. Patients were treated with theReza band and PPI medication simultaneously or only the Reza band. We studied complicationsrelated to the Reza band, analyzed Reflux Symptom Index (RSI) and Reflux Finding Score(RFS) before and after the application of the band up to 12 weeks. Results The Reza band was endured by 15 patients except one patient. One patient (6.25%)ceased wearing the band due to pain and discomfort in the neck. No major complications occurred,except one patient who reported mild neck discomfort when the band was applied. The mean value of RSI before the application of the Reza band was 12.31±6.43, which significantlyimproved at 8 weeks and 12 weeks (9.17±5.08, p=0.005 and 8.20±5.59, p=0.007, respectively)post-treatment. The mean value of RFS before the application of the Reza band was13.50±2.97, which significantly improved at 2, 4, 8, and 12 weeks (p＜0.05) post-treatment. Conclusion We conclude that the Reza band is safe and effective for the treatment of LPRDin properly selected patients.
Abstract
Background and Objectives The main treatment of laryngopharyngeal reflux disease(LPRD) includes life style modification and proton pump inhibitor (PPI) medication. However,LPRD is sometimes refractory to PPI medication. The Reza band has been developed toexert external pressure on the upper esophageal sphincter thus preventing gastric acid refluxto the larynx and pharynx. The aim of this study was to evaluate safety and efficacy of usingthe Reza band in patients with LPRD. Subjects and Methods We prospectively enrolled 16 LPRD patients who were refractoryto PPI medication and who had agreed to wear the Reza band. Patients were treated with theReza band and PPI medication simultaneously or only the Reza band. We studied complicationsrelated to the Reza band, analyzed Reflux Symptom Index (RSI) and Reflux Finding Score(RFS) before and after the application of the band up to 12 weeks. Results The Reza band was endured by 15 patients except one patient. One patient (6.25%)ceased wearing the band due to pain and discomfort in the neck. No major complications occurred,except one patient who reported mild neck discomfort when the band was applied. The mean value of RSI before the application of the Reza band was 12.31±6.43, which significantlyimproved at 8 weeks and 12 weeks (9.17±5.08, p=0.005 and 8.20±5.59, p=0.007, respectively)post-treatment. The mean value of RFS before the application of the Reza band was13.50±2.97, which significantly improved at 2, 4, 8, and 12 weeks (p＜0.05) post-treatment. Conclusion We conclude that the Reza band is safe and effective for the treatment of LPRDin properly selected patients.
참고문헌 (18)
- Schreiber S, "Pathophysiological mechanisms of extraesophageal reflux in otolaryngeal disorders", Eur Arch Otorhinolaryngol, 266(1), pp.17~24 (2009)[DOI]
- Shin KS, "The role of psychological distress in laryngopharyngeal reflux patients: a prospective questionnaire study", Clin Otolaryngol, 35(1), pp.25~30 (2010)[DOI]
- Szczesniak MM, "Upregulation of the esophago-UES relaxation response: a possible pathophysiological mechanism in suspected reflux laryngitis", Neurogastroenterol Motil, 22(4), pp.381~386 (2010)[DOI]
- Szczesniak MM, "Mechanisms of esophagopharyngeal acid regurgitation in human subjects", PLoS One, 6(7), pp.e22630~ (2011)[DOI]
- 이윤재, "인후두 역류증의 약물요법에 적절한 약제 및 치료기간의 선택", 대한이비인후-두경부외과학회지, 57(10), pp.698~702 (2014), 대한이비인후과학회[DOI]
- Tae K, "The changes of reflux symptoms and laryngoscopic findings in treatment of patients with laryngopharyngeal reflux", J Korean Logo Phon, 16(1), pp.15~18 (2005)
- Slivers SL, "Prospective study of upper esophageal sphincter assist device for treating extraesophageal reflux", Otolaryngol Open J, 2(1), pp.31~38 (2016)
- Shaker R, "Prevention of esophagopharyngeal reflux by augmenting the upper esophageal sphincter pressure barrier", Laryngoscope, 124(10), pp.2268~2274 (2014)[DOI]
- Belafsky PC, "Validity and reliability of the reflux symptom index (RSI)", J Voice, 16(2), pp.274~277 (2002)[DOI]
- Belafsky PC, "The validity and reliability of the reflux finding score (RFS)", Laryngoscope, 111(8), pp.1313~1317 (2001)[DOI]
- 오재호, "인후두 역류질환에서 24시간 이중 탐침 산도 검사와 Reflux Finding Score, Reflux Symptom Index의 연관성", 대한이비인후-두경부외과학회지, 56(11), pp.706~710 (2013), 대한이비인후과학회[DOI]
- Berardi RR, "A critical evaluation of proton pump inhibitors in the treatment of gastroesophageal reflux disease", Am J Manag Care, 6(9 Suppl), pp.S491~S505 (2000)
- Park W, "Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response", Laryngoscope, 115(7), pp.1230~1238 (2005)[DOI]
- Ford CN, "Evaluation and management of laryngopharyngeal reflux", JAMA, 294(12), pp.1534~1540 (2005)[DOI]
- Jiao H, "Upper esophageal sphincter augmentation reduces pharyngeal reflux in nasogastric tube-fed patients", Laryngoscope (2017)[DOI]
- El-Rifai W, "Mechanisms of esophago-pharyngeal acid regurgitation in human subjects", PLoS One, 6(7), pp.e22630~ (2011)[DOI]
- Groen JN, "Supra-oesophageal manifestations of gastrooesophageal reflux disease", Eur J Gastroenterol Hepatol, 15(12), pp.1339~1350 (2003)[DOI]
- Rodriguez-Tellez M, "Supra-oesophageal manifestations of gastrooesophageal reflux disease", Drugs, 65(Suppl 1), pp.67~73 (2005)